METASTASES TO CHEST WALL

This adverse event was reported 347 times

These drugs are most commonly taken by patients reporting METASTASES TO CHEST WALL:

# Drug Count
0 LETROZOLE 67
1 LETROZOLE TABLETS 58
2 CAPECITABINE 50
3 CYCLOPHOSPHAMIDE 45
4 CYCLOPHOSPHAMIDE FOR INJECTION 45
5 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 45
6 FULVESTRANT 45
7 ANASTROZOLE 36
8 EVEROLIMUS 36
9 EXEMESTANE 34
See all common drugs associated with METASTASES TO CHEST WALL

METASTASES TO CHEST WALL is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Estrogen Receptor Antagonist [EPC] 46 0.0011
1 Aromatase Inhibitor [EPC] 98 0.0009
2 HER2/neu Receptor Antagonist [EPC] 31 0.0004
3 Calcitonin [EPC] 1 0.0003
4 Nucleoside Metabolic Inhibitor [EPC] 82 0.0003
5 Microtubule Inhibitor [EPC] 46 0.0003
6 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 5 0.0002
7 Alkylating Drug [EPC] 50 0.0002
8 Platinum-based Drug [EPC] 45 0.0002
9 Topoisomerase Inhibitor [EPC] 12 0.0002
See all drug classes enriched for association with METASTASES TO CHEST WALL